TechNVision Ventures Ltd — Important, 18-03-2026: Company Update

TechNVision Ventures' affiliate, Solix Technologies, has signed a Memorandum of Understanding with Symbiosis Center for Entrepreneurship & Innovation and Symbiosis Medical College for Women. This collaboration establishes a Center of Excellence focused on New Drug Development and Drug Repurposing. The initiative will leverage AI-driven translational drug discovery, initially targeting Alzheimer’s disease and antimicrobial resistance. This aims to accelerate therapeutic breakthroughs by integrating computational intelligence with molecular and clinical validation, potentially reducing pre-clinical risks and fostering healthcare innovation.